CD4 and neoplasm: These data show that tumor-specific CD4 T cells induce a phenotypical and functional change in TAMs in vivo, educating them not only to produce lower amounts of tumor-promoting factors, but also driving them to produce inflammatory factors that might assist in the CD4 T cell–mediated tumor rejection process.